New Delhi, 5 March 2024: The Delhi High Court has barred Natco Pharma from manufacturing and selling cancer drug Olaparib either under the brand name ‘BRACANAT’ or under other brand names till further orders.

“…the defendant (Natco) is in fact ......
View Details

Related News

• DCA Seizes Overpriced, misleading claim Medicine (26-06-2024)

---

• Inquiry demanded at Maharashtra Assembly on export nod for over 200 pharma companies without stability testing (26-06-2024)

---

• Spurious drug factory busted in Gandhinagar (26-06-2024)

---

• Gang involved in illegal drug trade busted; 11 arrested (26-06-2024)

---

• 90% of healthcare companies get a 'B+' on cybersecurity with medical devices (26-06-2024)

---

• US lawmakers questions FDAs drug inspection programme in India and China (25-06-2024)

---

• Two arrested with 36,000 bottles of banned cough syrup in Siliguri (25-06-2024)

---

• DoP further expands list of special invitees into committee constituted to reform pricing framework (25-06-2024)

---

• India key market for APIs, but patients forced to cough up crores to buy orphan drugs (25-06-2024)

---

• Govt considers ban on two antibiotics for poultry and animal feed supplements (25-06-2024)

---